Ag-Emtricitabine / Tenofovir Disoproxil Fumarate 300 mg

AG-EMTRICITABINE / TENOFOVIR DISOPROXIL FUMARATE 300 MG tablets are a combination medication used in the treatment of HIV. This oral medication is manufactured by Angita Pharma Inc. in Canada.

AG-EMTRICITABINE / TENOFOVIR DISOPROXIL FUMARATE 300 MG tablets are commonly used as part of a treatment regimen for HIV infection. This combination medication works by reducing the amount of HIV in the body, helping to manage the virus and improve immune function. It is often prescribed alongside other antiretroviral drugs to create a comprehensive treatment plan.

Common effects of AG-EMTRICITABINE / TENOFOVIR DISOPROXIL FUMARATE 300 MG tablets may include nausea, diarrhea, and headaches. Some individuals may also experience dizziness or fatigue. These effects vary among users and are not experienced by everyone who takes the medication.

AG-EMTRICITABINE / TENOFOVIR DISOPROXIL FUMARATE 300 MG tablets should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should be stored at room temperature, away from moisture and heat.

AG-EMTRICITABINE / TENOFOVIR DISOPROXIL FUMARATE 300 MG tablets may interact with other medications, including certain antiretroviral drugs, antibiotics, and medications used to treat hepatitis C. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.